Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 19, 2020
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Frederic Di Fiore, Olivier Bouché, Come Lepage, et al.
Diagnostics (Basel, Switzerland)|January 20, 2021
Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life ExperienceJulie Pellegrinelli, Olivier Chevallier, Sylvain Manfredi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2021
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trialsClémence Breton, Thomas Aparicio, Karine Le Malicot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 7, 2018
Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)Pierre Michel, Valerie Boige, Thierry Andre, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 5, 2020
Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III studySylvain Manfredi, Anthony Turpin, David Malka, et al.
Endocrine|July 1, 2017
Management of gastric neuro-endocrine tumours in a large French national cohort (GTE)Sylvain Manfredi, Thomas Walter, Eric Baudin, et al.
Acta Diabetologica|January 13, 2023
Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoringPauline Legris, Benjamin Bouillet, Justine Pâris, et al.
Clinical Pharmacokinetics|June 18, 2016
Bevacizumab Pharmacokinetics Influence Overall and Progression-Free Survival in Metastatic Colorectal Cancer PatientsMorgane Caulet, Thierry Lecomte, Olivier Bouché, et al.
EJNMMI Research|March 9, 2021
Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapyGuillaume Nodari, Romain Popoff, Jean Marc Riedinger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Pageof 11